ClinicalTrials.Veeva

Menu

Use of Pulsed Electromagnetic Fields for Postoperative Knee Pain

C

Center for Joint Surgery and Sports Medicine, Maryland

Status and phase

Unknown
Phase 2

Conditions

Osteoarthritis

Treatments

Device: Sham Device (Torino II)
Device: Active Device (Torino II)

Study type

Interventional

Funder types

Other

Identifiers

NCT01415856
Salvagno 20100977

Details and patient eligibility

About

The purpose of this study is to determine whether the Torino II device, which emits a pulsed electromagnetic field), will help to decrease pain and swelling after knee replacement surgery, and thereby decrease the use of narcotic medications after surgery.

Full description

The investigators are conducting a research study to determine if the Torino II, a pulsed electromagnetic fields (PEMF) device is helpful in reducing postoperative pain and swelling after total knee replacement surgery. Postoperative pain and swelling may cause discomfort that may directly influence functional recovery after surgery. By reducing pain and swelling immediately following surgery,the use of high doses of narcotic, NSAID, and Tyelenol pain killers can be reduced, and possibly avoided. Recovery can be maximized, as well.

The PEMF device that is being used (the Torino II) is distributed by Ivivi Health Sciences, and has been approved by the FDA for the treatment of pain and swelling following surgery. The device is non-invasive, and is fixed onto the outside of the dressing with Velcro straps. The device will give off electromagnetic pulses to target pain relief in the knee. PEMF devices have been in clinical use for decades, and to date, no reported side effects have occurred.

It is important to note that treatment will still follow the standard Meritus Medical Center protocol for knee replacement surgery. This includes pain medication, icing, and physical therapy. This standard protocol will be followed no matter what study group patients are assigned to. Participation in this study or lack thereof will not change the treatment protocol.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: greater than 18 years
  • Weight: less than 300 lbs.
  • Diagnosis: osteoarthritis
  • Type of Surgery: unilateral knee replacement

Exclusion criteria

  • No pacemaker or defibrillator.
  • No infection of the affected knee.
  • No previous open surgery of the affected knee.
  • No history of Rheumatoid Arthritis.
  • No more than 2 narcotic pills per month in the last 6 months for pain.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups, including a placebo group

Sham Device (Torino II)
Placebo Comparator group
Description:
Device is designed to appear to be giving treatment when it is not actually giving treatment. Patients will wear this for a duration of two weeks.
Treatment:
Device: Sham Device (Torino II)
Active Device (Torino II)
Active Comparator group
Description:
Device is giving treatment for 15 minutes every 2 hours for a total of two weeks.
Treatment:
Device: Active Device (Torino II)

Trial contacts and locations

1

Loading...

Central trial contact

Ralph T Salvagno, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems